Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.6635
-0.1614 (-19.57%)
Jan 28, 2026, 9:48 AM EST - Market open
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $22.84 million as of January 28, 2026. Its market cap has decreased by -91.93% in one year.
Market Cap
22.84M
Enterprise Value
27.85M
1-Year Change
-91.93%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $22.84M, a decrease of -82.75%. That is a compound annual growth rate of -78.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 28.40M | -19.13% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 32.75M |
| Dyadic International | 32.57M |
| Skye Bioscience | 32.38M |
| Outlook Therapeutics | 32.25M |
| AN2 Therapeutics | 32.06M |
| Genenta Science | 31.16M |
| Serina Therapeutics | 30.61M |
| Barinthus Biotherapeutics | 29.44M |